BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rodríguez AE, Fernández-Pereira C, Rodríguez-Granillo AM. Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry. World J Cardiol 2012; 4(8): 242-249 [PMID: 22953021 DOI: 10.4330/wjc.v4.i8.242]
URL: https://www.wjgnet.com/1949-8462/full/v4/i8/242.htm
Number Citing Articles
1
Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein, Ted E. Feldman, Elisabeth Ståhle, Antonio Colombo, Michael J. Mack, David R. Holmes, James W. Choi, Witold Ruzyllo, Grzegorz Religa, Jian Huang, Kristine Roy, Keith D. Dawkins, Friedrich Mohr. Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery TrialCirculation 2014; 129(23): 2388 doi: 10.1161/CIRCULATIONAHA.113.006689
2
Maryam Rahim Sheikh, Muhammad Shahjahan Khan, Zeb Saeed, Shumaila Furnaz, Hasanat Sharif. Outcome of coronary artery bypass grafting in a tertiary-care center in PakistanAsian Cardiovascular and Thoracic Annals 2015; 23(3): 276 doi: 10.1177/0218492314545620
3
Alfredo E. Rodriguez, Carlos Fernandez-Pereira, Juan Ramon Mieres, Alfredo Matias Rodriguez-Granillo. High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized DataDiagnostics 2023; 13(7): 1321 doi: 10.3390/diagnostics13071321
4
Alfredo E Rodríguez, Lorena Arismendi, Guadalupe Romero, Alfredo M Rodríguez-Granillo. Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabeticsExpert Review of Cardiovascular Therapy 2014; 12(3): 297 doi: 10.1586/14779072.2014.882770